Cyclodextrin Inclusion Complexes and Pharmaceutical Formulation Development
This community focuses on the design, synthesis, and evaluation of cyclodextrin-based inclusion complexes to enhance the solubility, stability, and delivery of pharmaceutical agents, as well as the formulation of solid dosage forms like tablets.
The work centers on the chemical modification of cyclodextrins to create host-guest systems that encapsulate poorly soluble drugs. Recurring applications include improving the bioavailability of specific compounds such as diclofenac sodium, losartan potassium, and trospium chloride. Methodologies frequently involve physicochemical characterization, thermal stability testing, and analytical techniques like capillary electrophoresis and liquid chromatography. The research also covers the development of solid dosage forms through direct compression and the use of excipients like magnesium stearate. While a subset of papers addresses "energy healing" and "biofield energy," the dominant technical strand is the supramolecular chemistry of cyclodextrin derivatives for drug delivery and formulation optimization.
The largest share of the community's output is found in sodium research, accounting for 0.2% of all sodium research, and 691 papers here. Magnesium and potassium research also feature prominently, with 433 and 290 papers respectively.
The community comprises 5,763 papers, publishing primarily in the International Journal of Pharmaceutics, Pharmaceutics, and the Journal of Pharmaceutical Sciences.
Recent work continues to focus on cyclodextrin applications in drug delivery, including the encapsulation of polyphenols and the development of supramolecular self-assemblies. There is also ongoing clinical research into the long-term efficacy and safety of xanomeline and trospium chloride for schizophrenia, alongside investigations into cyclodextrins as active therapeutic agents and their use in cosmetic and food industries.